UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The efficacy of sonographic measurement of inferior vena cava diameter as an estimate of central venous pressure

Cardiovascular ultrasound, 2016-08, Vol.14 (1), p.33-33, Article 33

2016

Volltextzugriff (PDF)

Feasibility of a voice-enabled automated platform for medical data collection: CardioCube

International journal of medical informatics (Shannon, Ireland), 2019-09, Vol.129, p.388-393

2019

Volltextzugriff (PDF)

The AWAKE-HF Study: Sacubitril/Valsartan Impact on Daily Physical Activity and Sleep in Heart Failure

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2021-03, Vol.21 (2), p.241-254

2021

Volltextzugriff (PDF)

PREDICTING HEART FAILURE EVENTS WITH HOME MONITORING: USE OF A NOVEL, WEARABLE NECKLACE TO MEASURE STROKE VOLUME, CARDIAC OUTPUT AND THORACIC IMPEDANCE

Journal of the American College of Cardiology, 2016-04, Vol.67 (13), p.1296-1296

2016

Volltextzugriff (PDF)

Usefulness of Serial Measurements of Inferior Vena Cava Diameter by Vscan TM to Identify Patients With Heart Failure at High Risk of Hospitalization

The American journal of cardiology, 2017-05, Vol.119 (10), p.1631-1636

2017

Volltextzugriff (PDF)

Usefulness of Serial Measurements of Inferior Vena Cava Diameter by VscanTM to Identify Patients With Heart Failure at High Risk of Hospitalization

The American journal of cardiology, 2017-05, Vol.119 (10), p.1631-1636

2017

Volltextzugriff (PDF)

Activity Sensors to Evaluate the Effect of Sacubitril/Valsartan on Quality‐of‐Life in Heart Failure: rational and design of the AWAKE‐HF study

ESC Heart Failure, 2019-12, Vol.6 (6), p.1313-1321

2019

Volltextzugriff (PDF)

Daily Activity Measured With Wearable Technology as a Novel Measurement of Treatment Effect in Patients With Coronary Microvascular Dysfunction: Substudy of a Randomized Controlled Crossover Trial

JMIR research protocols, 2017-12, Vol.6 (12), p.e255

2017

Volltextzugriff (PDF)

OPTIMIZING GUIDELINE DIRECTED MEDICAL THERAPY USING REMOTE PATIENT MONITORING AND ARTIFICIAL INTELLIGENCE IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION (TURING-HF)

Journal of the American College of Cardiology, 2024-04, Vol.83 (13), p.2436-2436

2024

Volltextzugriff (PDF)

Sleep Outcomes From AWAKE-HF: A Randomized Clinical Trial of Sacubitril/Valsartan vs Enalapril in Patients With Heart Failure and Reduced Ejection Fraction

Journal of cardiac failure, 2021-12, Vol.27 (12), p.1466-1471

2021

Volltextzugriff (PDF)

Digital Technologies in Heart Failure Management

Current cardiovascular risk reports, 2020-08, Vol.14 (8), p.9, Article 9

2020

Volltextzugriff (PDF)

SACUBITRIL/VALSARTAN VERSUS ENALAPRIL IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION: FINDINGS FROM AWAKE-HF, A RANDOMIZED, CLINICAL TRIAL USING A WEARABLE BIOSENSOR

Journal of the American College of Cardiology, 2019-03, Vol.73 (9), p.848-848

2019

Volltextzugriff (PDF)

SLEEP OUTCOMES FROM AWAKE-HF, A RANDOMIZED CLINICAL TRIAL WITH OPEN-LABEL EXTENSION OF SACUBITRIL/VALSARTAN VERSUS ENALAPRIL IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION

Journal of the American College of Cardiology, 2019-03, Vol.73 (9), p.849-849

2019

Volltextzugriff (PDF)

Differential Effects of Carvedilol and Metoprolol Succinate on Plasma Norepinephrine Release and Peak Exercise Heart Rate in Subjects With Chronic Heart Failure

Journal of cardiovascular pharmacology and therapeutics, 2008-03, Vol.13 (1), p.51-57

2008

Volltextzugriff (PDF)

DECREASING HOSPITAL UTILIZATION OF A HIGH RISK HEART FAILURE POPULATION IN A LARGE URBAN ACCOUNTABLE CARE ORGANIZATION: THE USE OF A CLINICAL PHARMACIST, SERIAL BIOMARKERS, AND POINT OF CARE ULTRASOUND

Journal of the American College of Cardiology, 2016-04, Vol.67 (13), p.1298-1298

2016

Volltextzugriff (PDF)

Leading the Way: Cardiology and the Future of HealthTech Innovation

Reviews in cardiovascular medicine, 2016-01, Vol.17 (1-2), p.67-68

2016

Volltextzugriff (PDF)

Usefulness of Serial Measurements of Inferior Vena Cava Diameter by VscanTMto Identify Patients With Heart Failure at High Risk of Hospitalization

The American journal of cardiology, 2017-05, Vol.119 (10), p.1631

2017

Volltextzugriff (PDF)

AWAKE-HF: Rationale and Design of a Study Using a Wearable Biosensor to Objectively Evaluate the Effect of Sacubitril/Valsartan Initiation on Measures of Physical Activity, Symptoms, and Sleep, as Health-Related Quality of Life Functions in Subjects with Heart Failure

Journal of cardiac failure, 2017-08, Vol.23 (8), p.S69

2017

Volltextzugriff (PDF)

183 - AWAKE-HF: Rationale and Design of a Study Using a Wearable Biosensor to Objectively Evaluate the Effect of Sacubitril/Valsartan Initiation on Measures of Physical Activity, Symptoms, and Sleep, as Health-Related Quality of Life Functions in Subjects with Heart Failure

Journal of cardiac failure, 2017-08, Vol.23 (8), p.S69-S69

2017

Volltextzugriff (PDF)

Usefulness of Serial Measurements of Inferior Vena Cava Diameter By Vscan™ to Identify Heart Failure Patients at High Risk of Hospitalization

The American journal of cardiology, 2017

2017

Volltextzugriff (PDF)

Implementation of a Home Monitoring System for Heart Failure Patients: A Feasibility Study

JMIR research protocols, 2017-03, Vol.6 (3), p.e46-e46

2017

Volltextzugriff (PDF)

Abstract 108: Impact of a Wireless "Wearable" Device to Measure Daily Activity in Patients With Coronary Microvascular Disease Treated With Late Na Channel Inhibition (ranolazine): a Substudy of the RWISE Clinical Trial

Circulation Cardiovascular quality and outcomes, 2017-03, Vol.10 (suppl_3)

2017

Volltextzugriff (PDF)

A Novel Score To Predict Peak VO2 in Subjects with CHF Receiving Optimal Medical Therapy

Journal of cardiac failure, 2006-08, Vol.12 (6), p.S17-S17

2006

Volltextzugriff (PDF)

Organizational Goals and Lower Management Job Satisfaction

Indian journal of industrial relations, 1984-10, Vol.20 (2), p.111-136

1984

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The efficacy of sonographic measurement of inferior vena cava diameter as an estimate of central venous pressure

Feasibility of a voice-enabled automated platform for medical data collection: CardioCube

The AWAKE-HF Study: Sacubitril/Valsartan Impact on Daily Physical Activity and Sleep in Heart Failure

PREDICTING HEART FAILURE EVENTS WITH HOME MONITORING: USE OF A NOVEL, WEARABLE NECKLACE TO MEASURE STROKE VOLUME, CARDIAC OUTPUT AND THORACIC IMPEDANCE

Usefulness of Serial Measurements of Inferior Vena Cava Diameter by Vscan TM to Identify Patients With Heart Failure at High Risk of Hospitalization

Usefulness of Serial Measurements of Inferior Vena Cava Diameter by VscanTM to Identify Patients With Heart Failure at High Risk of Hospitalization

Activity Sensors to Evaluate the Effect of Sacubitril/Valsartan on Quality‐of‐Life in Heart Failure: rational and design of the AWAKE‐HF study

Daily Activity Measured With Wearable Technology as a Novel Measurement of Treatment Effect in Patients With Coronary Microvascular Dysfunction: Substudy of a Randomized Controlled Crossover Trial

OPTIMIZING GUIDELINE DIRECTED MEDICAL THERAPY USING REMOTE PATIENT MONITORING AND ARTIFICIAL INTELLIGENCE IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION (TURING-HF)

Sleep Outcomes From AWAKE-HF: A Randomized Clinical Trial of Sacubitril/Valsartan vs Enalapril in Patients With Heart Failure and Reduced Ejection Fraction

Digital Technologies in Heart Failure Management

SACUBITRIL/VALSARTAN VERSUS ENALAPRIL IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION: FINDINGS FROM AWAKE-HF, A RANDOMIZED, CLINICAL TRIAL USING A WEARABLE BIOSENSOR

SLEEP OUTCOMES FROM AWAKE-HF, A RANDOMIZED CLINICAL TRIAL WITH OPEN-LABEL EXTENSION OF SACUBITRIL/VALSARTAN VERSUS ENALAPRIL IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION

Differential Effects of Carvedilol and Metoprolol Succinate on Plasma Norepinephrine Release and Peak Exercise Heart Rate in Subjects With Chronic Heart Failure

DECREASING HOSPITAL UTILIZATION OF A HIGH RISK HEART FAILURE POPULATION IN A LARGE URBAN ACCOUNTABLE CARE ORGANIZATION: THE USE OF A CLINICAL PHARMACIST, SERIAL BIOMARKERS, AND POINT OF CARE ULTRASOUND

Leading the Way: Cardiology and the Future of HealthTech Innovation

Usefulness of Serial Measurements of Inferior Vena Cava Diameter by VscanTMto Identify Patients With Heart Failure at High Risk of Hospitalization

AWAKE-HF: Rationale and Design of a Study Using a Wearable Biosensor to Objectively Evaluate the Effect of Sacubitril/Valsartan Initiation on Measures of Physical Activity, Symptoms, and Sleep, as Health-Related Quality of Life Functions in Subjects with Heart Failure

183 - AWAKE-HF: Rationale and Design of a Study Using a Wearable Biosensor to Objectively Evaluate the Effect of Sacubitril/Valsartan Initiation on Measures of Physical Activity, Symptoms, and Sleep, as Health-Related Quality of Life Functions in Subjects with Heart Failure

Usefulness of Serial Measurements of Inferior Vena Cava Diameter By Vscan™ to Identify Heart Failure Patients at High Risk of Hospitalization

Implementation of a Home Monitoring System for Heart Failure Patients: A Feasibility Study

Abstract 108: Impact of a Wireless "Wearable" Device to Measure Daily Activity in Patients With Coronary Microvascular Disease Treated With Late Na Channel Inhibition (ranolazine): a Substudy of the RWISE Clinical Trial

A Novel Score To Predict Peak VO2 in Subjects with CHF Receiving Optimal Medical Therapy

Organizational Goals and Lower Management Job Satisfaction

Suchergebnisse filtern